Naseem Amin, CEO of Orphalan, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Orphalan is working to transform rare disease treatment.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
